Neuphoria Therapeutics (NEUP) Accumulated Expenses (2023 - 2026)
Neuphoria Therapeutics' Accumulated Expenses came in at $370,997 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 87.4% from $2.95 million a year earlier and down 58.1% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Accumulated Expenses (2023 - 2026) Analysis & Trends
Going back to fiscal Q4 2023, Neuphoria Therapeutics' Accumulated Expenses data covers 10 quarters.
- Accumulated Expenses carries a three-year compound annual growth rate of -32.1% (FY2023 to FY2026).
- Going back by fiscal year, Accumulated Expenses was $2.95 million in FY2025 (+101.6%), $1.46 million in FY2024 (+23.4%) and $1.19 million in FY2023.
- The fiscal Q4 2026 figure represents the lowest quarterly Accumulated Expenses in data going back to fiscal Q4 2023.
- Year-over-year, Accumulated Expenses increased in four of the last five quarters, with growth averaging 87.7%.
- Business Quant data shows NEUP's Accumulated Expenses at $886,124 (Q3 2026), $2.07 million (Q2 2026) and $3.67 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 370,997.00 |
| Mar 31, 2026 | 886,124.00 |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 684,989.00 |
| Dec 31, 2024 | 793,881.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2023 | 1.19 Mn |
API Access
Neuphoria Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();